HomeANTX • NASDAQ
add
AN2 Therapeutics Inc
Previous close
$2.54
Day range
$2.50 - $2.67
Year range
$2.20 - $22.22
Market cap
76.21M USD
Avg Volume
292.26K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 18.82M | 50.81% |
Net income | -16.90M | -42.70% |
Net profit margin | — | — |
Earnings per share | -0.57 | 6.56% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 107.30M | 11.70% |
Total assets | 138.74M | 35.28% |
Total liabilities | 14.04M | 95.37% |
Total equity | 124.70M | — |
Shares outstanding | 29.77M | — |
Price to book | 0.61 | — |
Return on assets | -32.16% | — |
Return on capital | -35.68% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -16.90M | -42.70% |
Cash from operations | -17.07M | -123.46% |
Cash from investing | 420.00K | -93.06% |
Cash from financing | -321.00K | — |
Net change in cash | -16.97M | -971.95% |
Free cash flow | -10.94M | -242.07% |
About
Founded
2017
Headquarters
Website
Employees
41